Fundraising Fox
/People
Sign in

Katie Ellias

Investor

Managing Partner at JDRF T1D Fund · Venture Partner at Zubi Capital

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Katie

881 people in our graph can introduce you to Katie.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Vivien Ho to introduce you to Katie

You →Vivien · together at WHARTON HEALTH CARE MANAGEMENT ALUMNI ASSOCIATION (2023–2025) →Katie

Ask Jamie Chen to introduce you to Katie

You →Jamie · together at Partners Healthcare →Katie

Ask Sam Okafor to introduce you to Katie

You →Sam · 7 people · together at Sofinnova Partners →Katie

Sign up to find every way you can get introduced to Katie

  • Your email: the people you already email who know Katie
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Katie
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Katie Ellias is a Venture Partner at Zubi Capital with over a decade of venture capital experience in life sciences, including biotech, medical devices, and digital health. She previously served as Managing Director of a single disease impact fund focused on venture philanthropy from 2018 to 2024, and has held board director and observer positions at 12+ early and later-stage companies across the US, Canada, and Europe. Her background includes product launches in interventional cardiology and expertise in cardiac surgery, structural heart, diabetes, and global M&A transactions.

Experience

  1. Zubi CapitalVenture Partnercurrent2025 — present
  2. KE Advisory LLCAdvisor/Consultantcurrent2025 — presentCambridge, MA
  3. SAb BiotherapeuticsBoard Membercurrent2023 — present
  4. FACCNE ⎮ French-American Chamber of Commerce, New EnglandBoard Membercurrent2025 — presentBoston, Massachusetts, United States
  5. WHARTON HEALTH CARE MANAGEMENT ALUMNI ASSOCIATIONVice President and Board Membercurrent2021 — presentPhiladelphia, Pennsylvania, United States
  6. T1D FundManaging Director2018 — 2024Boston, Massachusetts, United States
  7. SeraxisBoard Observer2021 — 2024Germantown, Maryland, United States
  8. DiogenXBoard Member2020 — 2024Marseille, Provence-Alpes-Côte d'Azur, France
  9. i2o TherapeuticsBoard Observer2020 — 2024Cambridge, Massachusetts, United States
  10. BiolinqBoard Observer2019 — 2024San Diego, California, United States
  11. VERALOX TherapeuticsBoard Member2019 — 2024Frederick, Maryland, United States
  12. Enthera PharmaceuticalsBoard Observer2018 — 2024Milan, Lombardy, Italy
  13. Capillary BiomedicalBoard Member2019 — 2022Irvine, California, United States
  14. Inversago PharmaBoard Observer2019 — 2021Montreal, Quebec, Canada
  15. Protomer TechnologiesBoard Observer2020 — 2021Pasadena, California, United States
  16. Pandion Therapeutics (acquired by Merck)Board Observer2019 — 2020Cambridge, Massachusetts, United States
  17. Tech HealthIndependent Consultant2017 — 2018Greater Paris Metropolitan Region
  18. Endeavour VisionSenior Investment Director2016 — 2017Geneva, Paris
  19. Sofinnova PartnersPrincipal2011 — 2016Greater Paris Metropolitan Region
  20. MedtronicProgram Director Medtronic EUreka2009 — 2011Lausanne, Vaud, Switzerland
  21. MedtronicGroup Marketing Manager2009 — 2011Lausanne, Vaud, Switzerland
  22. MedtronicAd interim Business Director, Coronary Europe2010 — 2011Lausanne, Vaud, Switzerland
  23. MedtronicProduct Marketing Manager2008 — 2009Lausanne, Vaud, Switzerland
  24. MedtronicSenior Associate of Business Development2006 — 2008Minneapolis
  25. Partners HealthcareContracting Senior Associate2002 — 2004Boston
  26. McKinsey & CompanyBusiness Analyst2000 — 2002Boston

Skills & more

StartupsVenture FinancingExecutive Coaching1Compensation Committee1Cross border1FinanceBoard DevelopmentDue DiligenceInternational Business DevelopmentDeal ExecutionInterpersonal SkillsBoard Level
+12 moreBusiness DevelopmentProduct LaunchMarketingNegotiationInterventional CardiologyCardiac SurgeryMedical DevicesCommercializationStrategyManagementLeadershipCross-functional Team Leadership

Languages English · French

From Katie's professional profile.

Colleagues at JDRF T1D Fund

Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures

Frequently asked questions

Who is Katie Ellias?
Katie Ellias is a Venture Partner at Zubi Capital with over a decade of venture capital experience in life sciences, including biotech, medical devices, and digital health. She previously served as Managing Director of a single disease impact fund focused on venture philanthropy from 2018 to 2024, and has held board director and observer positions at 12+ early and later-stage companies across the US, Canada, and Europe. Her background includes product launches in interventional cardiology and expertise in cardiac surgery, structural heart, diabetes, and global M&A transactions.
Where does Katie Ellias work?
Katie Ellias is Managing Partner at JDRF T1D Fund.
What check size does Katie Ellias write?
Katie Ellias typically writes checks of $100K – $5M.
Where did Katie Ellias go to school?
Katie Ellias studied at The Wharton School (MBA, Health Care); Yale University (BA, Political Science); BB&N.

Same school

Shared employers

Also worked at Protomer Technologies1

Seth LieblichInvestment Team at 8VC